Lupus erythematosus is a chronic autoimmune disease that affects different organs and tissues in the body. It is characterized by inflammation and tissue damage caused by autoantibodies that attack healthy cells and tissues. The diagnosis of lupus erythematosus is based on a combination of clinical findings, laboratory investigations, and imaging studies. In this blog post, we will discuss the laboratory investigations used in the diagnosis and management of lupus erythematosus.
Complete blood count (CBC)
CBC is a routine blood test that measures the number and types of blood cells in the body. It includes the measurement of red blood cells, white blood cells, and platelets. In lupus erythematosus, CBC can show anemia, leukopenia, and thrombocytopenia, which are common hematologic manifestations of the disease.
Antinuclear antibodies (ANA)
ANA are autoantibodies that target components of the cell nucleus. They are found in almost all patients with lupus erythematosus and are used as a screening test for the disease. ANA can also be positive in other autoimmune diseases, infections, and certain drugs, so further testing is needed to confirm the diagnosis of lupus erythematosus.
Anti-double stranded DNA (anti-dsDNA) antibodies
Anti-dsDNA antibodies are a specific type of ANA that target double-stranded DNA. They are highly specific for lupus erythematosus and are used as a diagnostic marker for the disease. Their levels correlate with disease activity and can be used to monitor the response to treatment.
Anti-Smith antibodies
Anti-Smith antibodies are another type of ANA that are highly specific for lupus erythematosus. They are found in about 30% of patients with the disease and are associated with more severe disease manifestations, such as kidney involvement.
Complement levels
Complement is a group of proteins that play a key role in the immune response. In lupus erythematosus, complement levels can be decreased due to consumption by immune complexes, which are formed by the binding of autoantibodies to antigens. Low complement levels are associated with disease activity and can be used to monitor the response to treatment.
Rheumatoid factor (RF)
RF is an autoantibody that targets the Fc portion of immunoglobulin G (IgG) antibodies. It is commonly found in patients with rheumatoid arthritis, but can also be positive in patients with lupus erythematosus. RF positivity in lupus erythematosus is associated with an increased risk of joint involvement and other rheumatic manifestations.
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
ESR and CRP are nonspecific markers of inflammation that can be elevated in various conditions, including lupus erythematosus. They are not specific for the disease, but can be used to monitor disease activity and response to treatment.
In conclusion, the laboratory investigations used in the diagnosis and management of lupus erythematosus include CBC, ANA, anti-dsDNA antibodies, anti-Smith antibodies, complement levels, RF, ESR, and CRP. These tests help to confirm the diagnosis, assess disease activity, monitor organ involvement, and evaluate response to treatment. A combination of clinical findings and laboratory investigations is essential for the accurate diagnosis and optimal management of lupus erythematosus.
